CPSC
This article was originally published in The Tan Sheet
Executive Summary
Commissioner Mary Sheila Gall's confirmation to chair consumer product safety agency delayed due to postponement of June 6 Senate Commerce Committee hearing. Sen. James Jeffords' (I-Vt.) defection from GOP continues to disrupt committee actions as panels are realigned. Trade groups, who view Gall as more industry-friendly, have expressed concern about delay (1"The Tan Sheet" May 14, In Brief). Gall, a holdover from George H. W. Bush's administration, is seen as less apt to aggressively publicize unsafe products. She recently voted to proceed with rulemaking on mandatory Rx-to-OTC switch child-resistant packaging regs, although action on rule is expected to move slowly, according to CHPA
You may also be interested in...
CPSC
Commissioner Mary Gall, Bush Administration nominee to assume chairman's post, is not expected to have "same ideological bent vis-a-vis child-resistant packaging as [current chairman] Ann Brown," Healthcare Compliance Packaging Council Exec Director Peter Mayberry suggests at HCPC's patient compliance symposium in Philadelphia May 8. CPSC's three commissioners serve staggered, seven-year terms; chairman serves at President's discretion. HCPC has criticized proposed rule requiring CRP on all new oral Rx-to-OTC switches and Gall has voiced concerns about placing added burdens on manufacturers. CPSC staff briefing package on proposed rule and comments is expected to be distributed to commissioners in late May/early June. Mayberry says
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands